Diversified Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.35M | Buy |
8,626
+3,072
| +55% | +$461K | 0.02% | 395 |
|
|
2026
Q1 | $848K | Sell |
5,554
-101
| -2% | -$15.5K | 0.02% | 510 |
|
|
2025
Q4 | $780K | Sell |
5,655
-28
| -0.5% | -$3.67K | 0.01% | 519 |
|
|
2025
Q3 | $729K | Buy |
5,683
+469
| +9% | +$57.2K | 0.01% | 501 |
|
|
2025
Q2 | $631K | Sell |
5,214
-237
| -4% | -$26.7K | 0.01% | 525 |
|
|
2025
Q1 | $608K | Buy |
5,451
+333
| +7% | +$35.5K | 0.02% | 511 |
|
|
2024
Q4 | $498K | Buy |
5,118
+19
| +0.4% | +$2.03K | 0.01% | 601 |
|
|
2024
Q3 | $586K | Buy |
5,099
+229
| +5% | +$26K | 0.01% | 549 |
|
|
2024
Q2 | $518K | Sell |
4,870
-186
| -4% | -$18.7K | 0.01% | 532 |
|
|
2024
Q1 | $489K | Buy |
5,056
+99
| +2% | +$10.2K | 0.01% | 517 |
|
|
2023
Q4 | $501K | Sell |
4,957
-163
| -3% | -$15.7K | 0.02% | 506 |
|
|
2023
Q3 | $522K | Buy |
5,120
+517
| +11% | +$52.5K | 0.02% | 449 |
|
|
2023
Q2 | $464K | Sell |
4,603
-2,247
| -33% | -$225K | 0.02% | 486 |
|
|
2023
Q1 | $630K | Buy |
6,850
+1,320
| +24% | +$115K | 0.02% | 386 |
|
|
2022
Q4 | $502K | Buy |
5,530
+2,256
| +69% | +$190K | 0.02% | 421 |
|
|
2022
Q3 | $249K | Sell |
3,274
-6,518
| -67% | -$540K | 0.01% | 609 |
|
|
2022
Q2 | $828K | Buy |
9,792
+188
| +2% | +$16.5K | 0.03% | 260 |
|
|
2022
Q1 | $843K | Sell |
9,604
-740
| -7% | -$64.1K | 0.03% | 298 |
|
|
2021
Q4 | $905K | Buy |
10,344
+907
| +10% | +$75.3K | 0.03% | 285 |
|
|
2021
Q3 | $772K | Sell |
9,437
-152
| -2% | -$13.7K | 0.03% | 283 |
|
|
2021
Q2 | $875K | Sell |
9,589
-175
| -2% | -$15.6K | 0.03% | 263 |
|
|
2021
Q1 | $835K | Buy |
9,764
+937
| +11% | +$84.1K | 0.03% | 247 |
|
|
2020
Q4 | $834K | Sell |
8,827
-15
| -0.2% | -$1.31K | 0.03% | 236 |
|
|
2020
Q3 | $769K | Buy |
8,842
+14
| +0.2% | +$1.21K | 0.04% | 228 |
|
|
2020
Q2 | $771K | Buy |
8,828
+27
| +0.3% | +$2.33K | 0.04% | 193 |
|
|
2020
Q1 | $726K | Buy |
8,801
+8
| +0.1% | +$714 | 0.04% | 159 |
|
|
2019
Q4 | $833K | Sell |
8,793
-28
| -0.3% | -$2.51K | 0.04% | 158 |
|
|
2019
Q3 | $767K | Sell |
8,821
-406
| -4% | -$36.5K | 0.04% | 141 |
|
|
2019
Q2 | $843K | Sell |
9,227
-673
| -7% | -$57K | 0.04% | 142 |
|
|
2019
Q1 | $853K | Hold |
9,900
| – | – | 0.04% | 143 |
|
|
2018
Q4 | $761K | Buy |
+9,900
| New | +$771K | 0.04% | 142 |
|
Other funds holding NVS
Diversified Trust's NVS Position: Q2 2026 in Review
Diversified Trust increased its Novartis (NVS) stake by 55% in Q2 2026, buying an estimated $461K and bringing the position to 8,626 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #395.
Diversified Trust first reported a position in NVS in Q4 2018 and has held it in 31 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Diversified Trust held 8,626 shares of Novartis worth $1.35M as of Q2 2026.
- Diversified Trust bought 3,072 Novartis shares in Q2 2026, an estimated $461K.
- Novartis made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #395 holding.
- Diversified Trust first reported a position in Novartis in Q4 2018 and has held it in 31 quarters since.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.